P85β phosphoinositide 3-kinase regulates CD28 coreceptor function

Blood

Volumn 113, Issue 14, 2009, Pages 3198-3208

  Alcázar, Isabela ^a   Cortés, Isabel ^a   Zaballos, Angel ^a   Hernandez, Carmen ^a   Fruman, David A ^b   Barber, Domingo F ^a   Carrera, Ana C ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; CD28 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; PROTEIN P85 BETA; UNCLASSIFIED DRUG; CBL PROTEIN, MOUSE; ISOENZYME; NEDD4 UBIQUITIN PROTEIN LIGASES; PHOSPHATIDYLINOSITOL KINASE; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME SUBUNIT; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SRC HOMOLOGY DOMAIN; T LYMPHOCYTE RECEPTOR GENE;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ANIMALS; ANTIGENS, CD28; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENES, T-CELL RECEPTOR; HUMANS; ISOENZYMES; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-CBL; SRC HOMOLOGY DOMAINS; T-LYMPHOCYTES; UBIQUITIN-PROTEIN LIGASES;

EID: 65349138964     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-152942     Document Type: Article

References (60)

1. Acuto O, Mise-Omata S, Mangino G, Michel F. Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. Immunol Rev. 2003;192:21-31.
2. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 1998;92:83-92.
3. Bubeck Wardenburg J, Fu C, Jackman JK, et al. Phosphorylation of SLP-76 by the ZAP-70 protein- tyrosine kinase is required for T-cell receptor function. J Biol Chem. 1996;271:19641-19644.
4. Kelly K, Siebenlist U. Immediate-early genes induced by antigen receptor stimulation. Curr Opin Immunol. 1995;7:327-332.
5. Wülfing C, Sumen C, Sjaastad MD, Wu LC, Dustin ML, Davis MM. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat Immunol. 2002;3:42-47.
6. Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB, Bluestone JA. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J Immunol. 1996;157:3909-3917.
7. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism?. J Exp Med. 1996;184:1-8.
8. Schwartz RH. Tcell anergy. Annu Rev Immunol. 2003;21:305-334.
9. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell. 1994;76:275-285.
10. Bertram EM, Lau P, Watts TH. Temporal segregation of 4-1BB versus CD28-mediated costimula- tion: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J Immunol. 2002;168:3777-3785.
11. Halstead ES, Mueller YM, Altman JD, Katsikis PD. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol. 2002;3:536-541.
12. Mittrucker HW, Kursar M, Kohler A, Hurwitz R, Kaufmann SH. Role of CD28 for the generation and expansion of antigen-specific CD8(+) T lymphocytes during infection with Listeria monocytogenes. J Immunol. 2001;167:5620-5627.
13. Suresh M, Whitmire JK, Harrington LE, et al. Role of CD28-B7 interactions in generation and maintenance of CD8 Tcell memory. J Immunol. 2001;167:5565-5573.
14. Bachmaier K, Krawczyk C, Kozieradzki I, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor CbI-b. Nature. 2000;403:211-216.
15. Chiang YJ, Kole HK, Brown K, et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature. 2000;403:216-220.
16. Zhang J, Bardos T, Li D, et al. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquiti- nation. J Immunol. 2002;169:2236-2240.
17. Krawczyk CM, Jones RG, Atfield A, et al. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b. J Immunol. 2005;174:1472-1478.
18. Fang D, Liu YC. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol. 2001;2:870-875.
19. Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitina- tion in T cells. J Biol Chem. 2001;276:4872-4878.
20. Krawczyk C, Bachmaier K, Sasaki T, et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in Tcells. Immunity. 2000;13:463-473.
21. NaramuraM, Kole HK, Hu RJ, Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA.1998;95:15547-15552.
22. Murphy MA, Schnall RG, Venter DJ, et al. Tissue hyperplas a and enhanced T-cell s gnall ng v a ZAP-70 in c-CbI-deficient mice. MoI Cell Biol. 1998;18:4872-4882.
23. Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC. The TyrK negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin- protein ligase. Science. 1999;286:309-312.
24. Thien CB, Bowtell DD, Langdon WY. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl- deficient thymocytes. J Immunol. 1999;162:7133-7139.
25. Shamim M, Nanjappa SG, Singh A, et al. Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 Tcells without affecting functional avidity. J Immunol. 2007;179:7233-7243.
26. Thien CB, Blystad FD, Zhan Y, et al. Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion. EMBO J. 2005;24:3807-3819.
27. Naramura M, Jang IK, Kole H, Huang F, Haines D, Gu H. c-Cbl and Cbl-b regulate Tcell responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol. 2002;12:1192-1199.
28. Deane JA, Fruman DA. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol. 2004;22:563-598.
29. Fruman DA, Snapper SB, Yballe CM, et al. B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science. 1999;283:393-397.
30. Borlado LR, Redondo C, Alvarez B, et al. Increased phosphoinositide 3-kinase activityin- duces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J. 2000;14:895-903.
31. Sasaki T, Irie-Sasaki J, Jones RG, et al. Function of PI3Kgamma in thymocyte development, Tcell activation, and neutrophil migration. Science. 2000;287:1040-1046.
32. Okkenhaug K, Bilancio A, Farjot G, et al. Impaired B and TCR signaling in p110delta PI 3-kinase mutant mice. Science. 2002;297:1031-1034.
33. Deane JA, Trifilo MJ, Yballe CM, Choi S, Lane TE, Fruman DA. Enhanced Tcell proliferation in mice lacking the p85beta subunit of phosphoino- sitide 3-kinase. J Immunol. 2004;172:6615-6625.
34. Barber DF, Bartolomé A, Hernández C, et al. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a murine systemic lupus model. Nat Med. 2005;11:933-935.
35. Alcázar I, Marqués M, Kumar A, et al. Phospho- inositide 3-kinase gamma participates in T cell receptor-induced T cell activation. J Exp Med. 2007;204:2977-2987.
36. Truitt KE, Hicks CM, Imboden JB. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat Tcells. J Exp Med. 1994;179:1071-1076.
37. Prasad KV, Cai YC, Raab M, et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidyl- inositol 3-kinase by a cytoplasmic Tyr(P)-Met- Xaa-Met motif. Proc Natl Acad Sci USA. 1994; 91:2834-2838.
38. Stein PH, Fraser JD, Weiss A. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with PI3K. Mol Cell Biol. 1994;14:3392-3402.
39. Pages F, Ragueneau M, Rottapel R, et al. Binding of phosphatidylinositol- 3-OH kinase to CD28 is required for T-cell signalling. Nature. 1994;369:327-329.
40. Pagès F, Ragueneau M, Klasen S, et al. Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidyl- inositol 3-kinase association. J Biol Chem. 1996;271:9403-9409.
41. Mamalaki C, Elliott J, Norton T, et al. Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleopro- tein and endogenous superantigen. Dev Immunol. 1993;3:159-174.
42. Jimenez C, Jones DR, Rodríguez-Viciana P, et al. Identification and characterization of a new onco- gene derived from the regulatory subunit of phos- phoinositide 3-kinase. EMBO J. 1998;17:743-753.
43. Geering B, Cutillas PR, Nock G, Gharbi SI, Vanhaesebroeck B. Class IAphosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA. 2007;104:7809-7814.
44. Hartley D, Meisner H, Corvera S. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto- oncogenec-cbl. J Biol Chem. 1995;270:18260-18263.
45. Jeon MS, Atfield A, Venuprasad K, et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell an- ergy induction. Immunity. 2004;21:167-177.
46. Mueller DL. E3 ubiquitin ligases as T cell anergy factors. Nat Immunol. 2004;5:883-890.
47. Heissmeyer V, Macián F, Im SH, et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol. 2004;5:255-265.
48. Panigada M, Porcellini S, Barbier E, et al. Constitutive endocytosis and degradation of the pre- T cell receptor. J Exp Med. 2002;195:1585-1597.
49. Magnifico A, Ettenberg S, Yang C, et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem. 2003;278:43169-43177.
50. Mencacci A, Del Sero G, Cenci E, et al. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med. 1998;187:307-317.
51. Mencacci A, Spaccapelo R, Del Sero G, et al. CD4+ T-helper-cell responses in mice with low- level Candida albicans infection. Infect Immun. 1996;64:4907-4914.
52. Li W, Whaley CD, Mondino A, Mueller DL. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science. 1996;271:1272-1276.
53. Okkenhaug K, Wu L, Garza KM, et al. Apoint mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol. 2001;2:325-332.
54. Garcon F, Patton DT, Emery JL, et al. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 het- erodimer. Blood. 2008;111:1464-1471.
55. Carrera AC, Rodriguez-Borlado L, Martinez- Alonso C, Merida I. T cell receptor-associated alpha-phosphatidylinositol 3-kinase becomes activated by T cell receptor cross-linking and requires pp56lck. J Biol Chem. 1994;269:19435-19440.
56. Zhang W, Samelson LE. The role of membrane- associated adaptors in T cell receptor signalling. Semin Immunol. 2000;12:35-41.
57. Oak JS, Deane JA, Kharas MG, et al. Sjogren's syndrome-like disease in mice with T cells lacking class 1Aphosphoinositide-3-kinase. Proc Natl Acad Sci USA. 2006;103:16882-16887.
58. Brachmann SM, Yballe CM, Innocenti M, et al. Role of phosphoinositide 3-kinase regulatory iso- forms in development and actin rearrangement. Mol Cell Biol. 2005;25:2593-2606.
59. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. Regulation of the p85/p110 phos- phatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol. 1998;18:1379-1387.
60. Patton DT, Garden OA, Pearce WP, et al. Cutting edge: the phosphoinositide 3-kinase p110 delta is critical forthe function of CD4+CD25+Foxp3 + regulatory T cells. J Immunol. 2006;177:6598-6602.